Labcorp Holdings Net Change in Intangible Assets 2010-2025 | LH
Labcorp Holdings annual/quarterly net change in intangible assets history and growth rate from 2010 to 2025. Net change in intangible assets can be defined as the overall change from the sale and purchase of intangible assets including patents, rights and capitalized software.
- Labcorp Holdings net change in intangible assets for the quarter ending June 30, 2025 was $0M, a 0% increase year-over-year.
- Labcorp Holdings net change in intangible assets for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.
- Labcorp Holdings annual net change in intangible assets for 2024 was $0B, a 0% decline from 2023.
- Labcorp Holdings annual net change in intangible assets for 2023 was $0B, a 0% decline from 2022.
- Labcorp Holdings annual net change in intangible assets for 2022 was $0B, a 0% decline from 2021.
| Labcorp Holdings Annual Net Change in Intangible Assets (Millions of US $) |
|
|---|---|
| 2024 | $N/A |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $N/A |
| 2018 | $N/A |
| 2017 | $-3 |
| 2016 | $0 |
| 2015 | $N/A |
| 2014 | $N/A |
| 2013 | $0 |
| 2012 | $-3 |
| 2011 | $N/A |
| 2010 | $0 |
| 2009 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.380B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.306B | 27.32 |
| CVS Health (CVS) | United States | $83.088B | 10.33 |
| Elevance Health (ELV) | United States | $65.860B | 8.86 |
| Cencora (COR) | United States | $56.044B | 18.67 |
| DiDi Global (DIDIY) | China | $26.733B | 28.40 |
| Natera (NTRA) | United States | $21.934B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.271B | 0.00 |
| ICON (ICLR) | Ireland | $13.654B | 13.14 |
| CochLear (CHEOY) | Australia | $13.302B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.903B | 34.15 |
| Solventum (SOLV) | United States | $12.500B | 12.90 |
| Viatris (VTRS) | United States | $11.799B | 4.20 |
| Revvity (RVTY) | United States | $10.214B | 18.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.176B | 0.00 |
| Avantor (AVTR) | United States | $8.631B | 12.66 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.258B | 0.00 |
| HealthEquity (HQY) | United States | $8.040B | 35.22 |
| Charles River Laboratories (CRL) | United States | $7.517B | 14.26 |
| Bausch + Lomb (BLCO) | Canada | $4.874B | 32.79 |
| Sotera Health (SHC) | United States | $4.221B | 23.59 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| BrightSpring Health Services (BTSG) | United States | $3.848B | 29.35 |
| GeneDx Holdings (WGS) | United States | $3.344B | 76.59 |
| Surgery Partners (SGRY) | United States | $2.946B | 37.06 |
| Alignment Healthcare (ALHC) | United States | $2.899B | 0.00 |
| Concentras Parent (CON) | United States | $2.871B | 18.21 |
| Organon (OGN) | United States | $2.353B | 2.56 |
| Premier (PINC) | United States | $1.978B | 15.01 |
| Progyny (PGNY) | United States | $1.873B | 39.60 |
| Ardent Health (ARDT) | United States | $1.785B | 6.89 |
| PACS (PACS) | United States | $1.705B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.282B | 8.56 |
| GoodRx Holdings (GDRX) | United States | $1.250B | 20.59 |
| Teladoc Health (TDOC) | United States | $1.214B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.974B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.779B | 4.56 |
| AMN Healthcare Services Inc (AMN) | United States | $0.676B | 8.36 |
| CareDx (CDNA) | United States | $0.663B | 12.22 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 200.00 |
| Nutex Health (NUTX) | United States | $0.534B | 8.08 |
| Omada Health (OMDA) | $0.497B | 0.00 | |
| So-Young (SY) | China | $0.488B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.485B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| SBC Medicals (SBC) | United States | $0.470B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 25.13 |
| Agilon Health (AGL) | United States | $0.369B | 0.00 |
| Oncology Institute (TOI) | United States | $0.367B | 0.00 |
| LifeMD (LFMD) | United States | $0.324B | 0.00 |
| Beauty Health (SKIN) | United States | $0.292B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.169B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |